168 related articles for article (PubMed ID: 16376262)
1. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis.
Tanaka R; Yasunaga Y; Hisatome T; Yamasaki T; Iwamori H; Ochi M
J Arthroplasty; 2005 Dec; 20(8):1049-54. PubMed ID: 16376262
[TBL] [Abstract][Full Text] [Related]
2. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty.
Beraudi A; Stea S; Cremonini S; Visentin M; Toni A
Artif Organs; 2009 Jul; 33(7):538-43. PubMed ID: 19566730
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty.
Wang CT; Lin YT; Chiang BL; Lee SS; Hou SM
Biomaterials; 2010 Jan; 31(1):77-82. PubMed ID: 19781765
[TBL] [Abstract][Full Text] [Related]
4. [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts].
Gallo J; Zdařilová A; Rajnochová Svobodová A; Ulrichová J; Radová L; Smižanský M
Acta Chir Orthop Traumatol Cech; 2010 Oct; 77(5):416-24. PubMed ID: 21040654
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
6. Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements.
Clarke SA; Brooks RA; Hobby JL; Wimhurst JA; Myer BJ; Rushton N
Acta Orthop Scand; 2001 Oct; 72(5):491-8. PubMed ID: 11728077
[TBL] [Abstract][Full Text] [Related]
7. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.
Takei I; Takagi M; Ida H; Ogino T; Santavirta S; Konttinen YT
J Rheumatol; 2000 Apr; 27(4):894-9. PubMed ID: 10782812
[TBL] [Abstract][Full Text] [Related]
8. High levels of substance P and CGRP in pseudosynovial fluid from patients with aseptic loosening of their hip prosthesis.
Qian Y; Zeng BF; Zhang XL; Jiang Y
Acta Orthop; 2008 Jun; 79(3):342-5. PubMed ID: 18622837
[TBL] [Abstract][Full Text] [Related]
9. Low IGF-I in synovial fluid and serum in patients with aseptic prosthesis loosening.
Andersson MK; Stark A; Anissian L; Mohan S; Tsai JA
Acta Orthop; 2005 Jun; 76(3):320-5. PubMed ID: 16156457
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines and bone turnover markers].
Odrowaz-Sypniewska G; Lis K; Biliński PJ
Przegl Epidemiol; 2002; 56 Suppl 4():39-45. PubMed ID: 14750259
[TBL] [Abstract][Full Text] [Related]
11. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
Kaneyama K; Segami N; Nishimura M; Suzuki T; Sato J
Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189
[TBL] [Abstract][Full Text] [Related]
12. Substance P stimulates production of interleukin 1beta and tumor necrosis factor alpha in fibroblasts from hip periprosthetic membrane.
Qian Y; Zeng BF; Zhang XL; Jiang Y
J Arthroplasty; 2008 Jun; 23(4):581-5. PubMed ID: 18514878
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C levels in pseudosynovial fluid of loose hip prostheses.
Hasegawa M; Sudo A; Nagakura T; Hirata H; Kinoshita N; Yoshida T; Uchida A
Scand J Rheumatol; 2005; 34(6):464-8. PubMed ID: 16393770
[TBL] [Abstract][Full Text] [Related]
14. The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis.
Chiba J; Rubash HE; Kim KJ; Iwaki Y
Clin Orthop Relat Res; 1994 Mar; (300):304-12. PubMed ID: 7510596
[TBL] [Abstract][Full Text] [Related]
15. Cytokines and osteolysis around total hip prostheses.
Stea S; Visentin M; Granchi D; Ciapetti G; Donati ME; Sudanese A; Zanotti C; Toni A
Cytokine; 2000 Oct; 12(10):1575-9. PubMed ID: 11023677
[TBL] [Abstract][Full Text] [Related]
16. Plasma cytokines as markers of aseptic prosthesis loosening.
Hundrić-Haspl Z; Pecina M; Haspl M; Tomicic M; Jukic I
Clin Orthop Relat Res; 2006 Dec; 453():299-304. PubMed ID: 16906105
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening.
Shi Q; Lajeunesse D; Reboul P; Martel-Pelletier J; Pelletier JP; Dehnade F; Fernandes JC
J Rheumatol; 2002 Jul; 29(7):1437-45. PubMed ID: 12136903
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover markers and cytokines in joint fluid: analyses in 10 patients with loose hip prosthesis and 39 with coxarthrosis.
Sypniewska G; Lis K; Bilinski PJ
Acta Orthop Scand; 2002 Oct; 73(5):518-22. PubMed ID: 12440494
[TBL] [Abstract][Full Text] [Related]
19. Correlation of aspiration results with aseptic loosening in total hip arthroplasty.
Chalmers PN; Sporer SM; Levine BR
J Arthroplasty; 2013 Oct; 28(9):1671-6. PubMed ID: 23806183
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein 1 expression in synovial fluid of patients with total hip arthroplasty.
Montesi M; Beraudi A; Stea S; Ancarani C; Traina F; Toni A
Artif Organs; 2012 May; 36(5):487-91. PubMed ID: 22171939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
